Real-world experience of cladribine treatment in relapsing-remitting multiple sclerosis: A Danish nationwide study-Reference-Cited by-同舟云学术

Real-world experience of cladribine treatment in relapsing-remitting multiple sclerosis: A Danish nationwide study

Published:2023-02 Issue: Volume:70 Page:104491
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Sorensen Per Soelberg^ORCID,Pontieri Luigi,Joensen Hanna,Heick Alex,Rasmussen Peter Vestergaard,Schäfer Jakob,Ratzer Rikke,Pihl Caroline Ellinore,Sellebjerg Finn,Magyari Melinda

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference27 articles.

1. Progressive multifocal leukoencephalopathy in a patient with systemic mastocytosis treated with cladribine;Alstadhaug;J Clin Virol,2017

2. 2-Chlorodeoxyadenosine (Cladribine) preferentially inhibits the biological activity of microglial cells;Aybar;Int. Immunopharmacol,2022

3. Both cladribine and alemtuzumab may effect MS via B-cell depletion;Baker;Neurol Neuroimmunol Neuroinflamm,2017

4. Cladribine tablets versus other disease-modifying oral drugs in achieving no evidence of disease activity (NEDA) in multiple sclerosis-A systematic review and network meta-analysis;Bartosik-Psujek;Mult Scler Relat Disord,2021

5. Cladribine (2-chlorodeoxyadenosine);Beutler;Lancet,1992

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of high efficacy therapies in older people with Multiple Sclerosis: A real-world evidence study;Multiple Sclerosis and Related Disorders;2024-10

2. Evaluation of therapy satisfaction with cladribine tablets in patients with RMS: Final results of the non-interventional study CLEVER;Multiple Sclerosis and Related Disorders;2024-10

3. Cladribine use trend in Latin America: the changes in patient profile impact in the drug effectiveness;Neurological Sciences;2024-09-11

4. Experience with the use of cladribine tablets in real-life clinical practice: independent analysis of data from 12 Russian clinical centres;Neurology, Neuropsychiatry, Psychosomatics;2024-08-07

5. Real-world effectiveness of cladribine as an escalation strategy for MS: Insights from the Czech nationwide ReMuS registry;Journal of Central Nervous System Disease;2024-07-24